Literature DB >> 1370576

Developmental switch of CREM function during spermatogenesis: from antagonist to activator.

N S Foulkes1, B Mellström, E Benusiglio, P Sassone-Corsi.   

Abstract

Mammalian spermatogenesis consists of a series of complex developmental processes controlled by the pituitary-hypothalamic axis. This flow of biochemical information is directly regulated by the adenylate cyclase signal transduction pathway. We have previously described the CREM (cyclic AMP-responsive element modulator) gene which generates, by cell-specific splicing, alternative antagonists of the cAMP transcriptional response. Here we report the expression of a novel CREM isoform (CREM tau) in adult testis. CREM tau differs from the previously characterized CREM antagonists by the coordinate insertion of two glutamine-rich domains that confer transcriptional activation function. During spermatogenesis there was an abrupt switch in CREM expression. In premeiotic germ cells CREM is expressed at low amounts in the antagonist form. Subsequently, from the pachytene spermatocyte stage onwards, a splicing event generates exclusively the CREM tau activator, which accumulates in extremely high amounts. This splicing-dependent reversal in CREM function represents an important example of developmental modulation in gene expression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370576     DOI: 10.1038/355080a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  115 in total

Review 1.  Transcriptional regulation by cAMP in the heart.

Authors:  F U Müller; J Neumann; W Schmitz
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

2.  Two distinct forms of the 64,000 Mr protein of the cleavage stimulation factor are expressed in mouse male germ cells.

Authors:  A M Wallace; B Dass; S E Ravnik; V Tonk; N A Jenkins; D J Gilbert; N G Copeland; C C MacDonald
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

3.  Cyclic AMP response element binding protein CREB and modulator protein CREM are products of distinct genes.

Authors:  T E Meyer; J F Habener
Journal:  Nucleic Acids Res       Date:  1992-11-25       Impact factor: 16.971

4.  The Ustilago maydis Clp1 protein orchestrates pheromone and b-dependent signaling pathways to coordinate the cell cycle and pathogenic development.

Authors:  Kai Heimel; Mario Scherer; David Schuler; Jörg Kämper
Journal:  Plant Cell       Date:  2010-08-20       Impact factor: 11.277

5.  PhosphoCREB and CREM/ICER: positive and negative regulation of proenkephalin gene expression in the paraventricular nucleus of the hypothalamus.

Authors:  D Borsook; O Smirnova; O Behar; S Lewis; L A Kobierski
Journal:  J Mol Neurosci       Date:  1999-02       Impact factor: 3.444

6.  Novel role for a sterol response element binding protein in directing spermatogenic cell-specific gene expression.

Authors:  Hang Wang; Jovenal T San Agustin; George B Witman; Daniel L Kilpatrick
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

Review 7.  Sterols in spermatogenesis and sperm maturation.

Authors:  Rok Keber; Damjana Rozman; Simon Horvat
Journal:  J Lipid Res       Date:  2012-10-23       Impact factor: 5.922

8.  Pituitary follicle-stimulating hormone (FSH) induces CREM gene expression in Sertoli cells: involvement in long-term desensitization of the FSH receptor.

Authors:  L Monaco; N S Foulkes; P Sassone-Corsi
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

9.  Reduction of spermatogenesis but not fertility in Creb3l4-deficient mice.

Authors:  Ibrahim M Adham; Thomas J Eck; Kerstin Mierau; Nicole Müller; Mahmoud A Sallam; Ilona Paprotta; Stephanie Schubert; Sigrid Hoyer-Fender; Wolfgang Engel
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

10.  An isoform of transcription factor CREM expressed during spermatogenesis lacks the phosphorylation domain and represses cAMP-induced transcription.

Authors:  W H Walker; B M Sanborn; J F Habener
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.